Surrogate and mediating endpoints: current status and future directions.
Prentice
Ross L
RL
D015415:Biomarkers / Q000032:analysis; D002986:Clinical Trials as Topic / Q000379:methods*; D016001:Confidence Intervals; D023381:Endpoint Determination / Q000379:methods*; D006801:Humans; D008297:Male; D016017:Odds Ratio; D011471:Prostatic Neoplasms / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000628:therapy; D012107:Research Design; D017211:Treatment Failure
D015415:Biomarkers